More articles from Structural Biology

p27 Activates CDK4 and Blocks Palbociclib-Mediated CDK4 Inhibition
Cancer Discovery Feb 2020, 10 (2) 172; DOI: 10.1158/2159-8290.CD-RW2020-001
Structures of mTORC1 and Associated Proteins Yield Mechanistic Insight
Cancer Discovery Dec 2019, 9 (12) 1642; DOI: 10.1158/2159-8290.CD-RW2019-159
The Structure of an Active BRAF Dimer Shows Active-Site Asymmetry
Cancer Discovery Nov 2019, 9 (11) OF7; DOI: 10.1158/2159-8290.CD-RW2019-150
Cholesterol-Induced Conformational Changes Drive Smoothened Activation
Cancer Discovery Jul 2018, 8 (7) OF14; DOI: 10.1158/2159-8290.CD-RW2018-093
MEK Binding to KSR Promotes Allosteric Activation of BRAF
Cancer Discovery Apr 2018, 8 (4) 385; DOI: 10.1158/2159-8290.CD-RW2018-033
DNMT3A DNA-Binding Residues Provide Specificity for CpG DNA Methylation
Cancer Discovery Apr 2018, 8 (4) OF14; DOI: 10.1158/2159-8290.CD-RW2018-028
JARID2 and AEBP2 Mimic Histone Tails to Promote PRC2 Activity
Cancer Discovery Mar 2018, 8 (3) 264; DOI: 10.1158/2159-8290.CD-RW2018-018
Determination of mTORC1 Complex Structures Reveals Regulatory Mechanisms
Cancer Discovery Feb 2018, 8 (2) OF11; DOI: 10.1158/2159-8290.CD-RW2018-001
The Structure of ABCG2 Provides Insight into Multidrug Resistance
Cancer Discovery Jul 2017, 7 (7) 664; DOI: 10.1158/2159-8290.CD-RW2017-110
Blinatumomab Has Activity in Patients with TKI-Refractory Ph⁺ ALL
Cancer Discovery Jun 2017, 7 (6) OF13; DOI: 10.1158/2159-8290.CD-RW2017-065

Main menu